RxDoctor Payments DataLook up a doctor →

Mary Denius

Family · Poplarville, MSNPI 1427349273

Payments from drug & device makers

$13,602in general payments, 2019–2025

Across 645 payments — averaging $21.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$3K
  • Merck$1K
  • Johnson & Johnson$884
  • Daiichi Sankyo Inc.$665
  • Exelixis Inc.$662
  • Eisai Inc.$504
  • plus $7K from 52 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis95$2,899
Merck56$1,041
Johnson & Johnson44$884
Daiichi Sankyo Inc.42$665
Exelixis Inc.17$662
Eisai Inc.29$504
Incyte Corporation34$503
AstraZeneca(2 entities)27$488
Lilly USA, LLC23$417
Bayer20$368
Gilead10$337
Bristol Myers Squibb15$300
Takeda Pharmaceuticals U.S.A., Inc.14$280
E.r. Squibb & Sons, L.L.C.16$261
Tersera Therapeutics LLC10$247
Sanofi12$235
AVEO Pharmaceuticals, Inc.7$227
Pfizer13$206
EMD Serono, Inc.12$205
Pharmaessentia USA Corporation8$201
AbbVie10$192
Rigel Pharmaceuticals, Inc.7$154
GSK9$154
Stemline Therapeutics Inc.7$146
Seagen Inc.8$142
Amgen7$125
Karyopharm Therapeutics Inc.7$120
Beigene USA, Inc.7$118
Ipsen Biopharmaceuticals, Inc5$104
Genentech USA, Inc.5$102
Sanofi-aventis U.S. LLC1$100
Array Biopharma Inc4$92
Puma Biotechnology, Inc.6$92
Astellas Pharma US Inc4$89
Pharmacyclics LLC, An Abbvie Company5$81
Syndax Pharmaceuticals, Inc.3$68
ADC Therapeutics America, Inc.3$66
Regeneron Healthcare Solutions, Inc.3$64
Morphosys, US Inc.4$63
G1 Therapeutics, Inc.4$62
Pharmacosmos Therapeutics Inc.4$62
Boehringer Ingelheim3$62
Acceleron Pharma, Inc.3$50
Myovant Sciences Inc.3$49
Beone Medicines USA, Inc.2$35
Taiho Oncology, Inc.2$32
Mirati Therapeutics, Inc.2$31
Blueprint Medicines Corporation2$29
Sobi, Inc1$29
Dova Pharmaceuticals2$29
Deciphera Pharmaceuticals Inc.1$21
Caris MPI, Inc.1$20
Recordati_rare_diseases_inc.1$20
Alnylam Pharmaceuticals Inc.1$19
Adaptive Biotechnologies Corporation1$17
Spectrum Pharmaceuticals Inc.1$14
Medtronic1$13
Secura Bio, Inc.1$10

How this compares

$13,602 in reported general payments places this provider in the 95th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi →

Medicare billing

Part B allowed, 2024
$2,457
Medicare patients
41
Services billed
42

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Poplarville

See the full list for Mississippi →

Where these figures come from

Is this you, or does something look wrong? →